Yellow zone Romatoloji / Vaskülitler

Takayasu Arteritis — Pulse Loss in a Young Woman, Diagnostic Delay, and Inability to Measure Disease Activity

Takayasu arteritis is an inflammation of the LARGE ARTERIES that OCCURS USUALLY IN WOMEN UNDER FORTY. DIAGNOSTIC DELAY IS A CHARACTERISTIC THAT CAN BE CONSIDERED TYPICAL FOR THIS DISEASE, and THE REASON IS THAT THE DISEASE PROGRESSES IN TWO STAGES.

IN THE FIRST STAGE, SYMPTOMS ARE NOT SPECIFIC TO ANY ORGAN: FATIGUE, FEVER, WEIGHT LOSS, MUSCLE AND JOINT PAIN occur; in this context, since the patient is a YOUNG AND OTHERWISE HEALTHY-LOOKING woman, the complaints are often attributed to PSYCHOLOGICAL FACTORS or ANEMIA.

IN THE SECOND STAGE, THE VESSELS NARROW and CLINICAL MANIFESTATIONS APPEAR — but AT THIS POINT, VESSEL DAMAGE HAS ALREADY OCCURRED. THE STEP THAT MOST COST-EFFECTIVELY BRINGS THE DIAGNOSIS TO MIND IS PHYSICAL EXAMINATION:

MEASURING BLOOD PRESSURE IN BOTH ARMS and COMPARING PULSES. A PROMINENT DIFFERENCE BETWEEN THE TWO ARMS, WEAK OR ABSENT PULSE, and HEARING A BRUIT OVER THE VESSEL suggests this diagnosis.

A CRITICAL PITFALL IS THIS: IN A PATIENT WITH NARROWED ARM ARTERIES, THE MEASURED BLOOD PRESSURE APPEARS LOWER THAN THE TRUE VALUE, and THE PATIENT MAY BE ASSUMED TO HAVE NORMAL OR LOW BLOOD PRESSURE EVEN IF THEY ARE HYPERTENSIVE.

THE MOST DIFFICULT ASPECT IS THAT DISEASE ACTIVITY CANNOT BE RELIABLY MEASURED: VESSEL DAMAGE MAY PROGRESS EVEN WHEN INFLAMMATORY MARKERS ARE NORMAL.

ALL DOSAGES SHOULD BE VERIFIED FROM THE INSTITUTIONAL PROTOCOL.

Rapid management

  • DELAYED DIAGNOSIS CAN BE CONSIDERED THE RULE IN THIS DISEASE, AND THE REASON IS A TWO-STAGE COURSE.
  • FIRST STAGE — THE SYMPTOMS ARE NOT SPECIFIC TO ANY ORGAN:
  • FATIGUE, FEVER, WEIGHT LOSS, NIGHT SWEATS, MUSCLE AND JOINT PAIN; since the patient appears YOUNG and OTHERWISE HEALTHY, the complaints are frequently ATTRIBUTED TO PSYCHOLOGICAL ISSUES or ANEMIA.
  • SECOND STAGE — THE BLOOD VESSELS HAVE NARROWED AND FINDINGS EMERGE, but BY THIS STAGE, VASCULAR DAMAGE HAS ALREADY OCCURRED.
  • THE STEP THAT BRINGS THE DIAGNOSIS TO MIND IN THE CHEAPEST WAY IS THE EXAMINATION:
  • MEASUREMENT OF BLOOD PRESSURE IN BOTH ARMS, COMPARISON OF PULSES, AND AUSCULTATION FOR BRUITS OVER THE VESSELS.
  • CONCERNING FINDINGS:
  • SIGNIFICANT BLOOD PRESSURE DIFFERENCE BETWEEN TWO ARMS, WEAK OR UNDETECTABLE PULSE, VASCULAR BRUIT, PAIN AND FATIGUE INCREASING WITH ARM USE, UNEXPLAINED HYPERTENSION IN A YOUNG PATIENT (may be due to renal artery stenosis), DIZZINESS, AND BLURRED VISION.
  • CRITICAL TRAP — IN A PATIENT WITH NARROWED ARM VESSELS, THE MEASURED BLOOD PRESSURE COMES OUT LOWER THAN THE REAL VALUE: even though the patient is HYPERTENSIVE, they are CONSIDERED NORMOTENSIVE or HYPOTENSIVE and ARE NOT TREATED; this situation SILENTLY PROGRESSES ORGAN DAMAGE → MEASUREMENTS SHOULD BE TAKEN IN BOTH ARMS AND, IF NECESSARY, LEGS, AND THE HIGHEST VALUE SHOULD BE CONSIDERED.
  • THE MOST DIFFICULT ASPECT — ACTIVITY CANNOT BE RELIABLY MEASURED:
  • VASCULAR DAMAGE MAY PROGRESS EVEN WHEN INFLAMMATORY MARKERS ARE NORMAL → monitoring CANNOT BE BASED SOLELY ON THE MARKERS, IMAGING AND CLINICAL FINDINGS ARE EVALUATED TOGETHER.
  • PREGNANCY SHOULD BE PLANNED IN ADVANCE (relevant protocol).
  • GIANT CELL ARTERITIS HAS A SEPARATE PROTOCOL AND THE AGE GROUP AND LOCATION OF INVOLVEMENT ARE DIFFERENT.
  • ALL DOSES MUST BE VERIFIED FROM THE INSTITUTIONAL PROTOCOL.
DrugAdultPediatricRouteDuration
REASON FOR DELAYED DIAGNOSIS — two-stage course The two-stage progression of the disease makes delayed diagnosis almost inevitable for this illness, and the cost of the delay is permanent vascular damage. In the first stage, inflammation has begun in the vessel wall, but the vessel has not yet narrowed significantly; therefore, the patient's complaints are only those of a general illness. Fatigue, fever, weight loss, and muscle pain are complaints that can be seen in almost any disease and are often attributed to other causes in a young woman. In tests performed during this period, inflammation markers may be found elevated, but this is not specific either. In the second stage, when vessel narrowing progresses, symptoms appear and diagnosis becomes relatively easier; however, the structural damage that occurs in the vessel wall at that stage is irreversible. Therefore, catching the patient in the first stage is important. IN THE FIRST STAGE, THE SYMPTOMS ARE NOT SPECIFIC TO ANY ORGAN: FATIGUE, FEVER, WEIGHT LOSS, NIGHT SWEATS, MUSCLE AND JOINT PAIN. Since the patient appears YOUNG and OTHERWISE HEALTHY, the complaints are ATTRIBUTED TO PSYCHOLOGICAL ISSUES or ANEMIA. IN THE SECOND STAGE, THE BLOOD VESSELS HAVE NARROWED AND FINDINGS EMERGE; however, BY THIS STAGE, VASCULAR DAMAGE HAS ALREADY OCCURRED It can also be seen in adolescents, and the same delay occurs. — At the first assessment
CHEAPEST DIAGNOSTIC STEP — blood pressure and pulse in both arms Measuring blood pressure from both arms and comparing pulses is the cheapest and fastest step that brings this disease to mind; it requires no test and takes a few minutes. On the other hand, in routine practice, blood pressure is usually measured in only one arm and pulses are not compared; this habit causes the most prominent physical sign of the disease to be overlooked. If a young patient has unexplained fatigue, fever, and weight loss, this examination should be done. A significant blood pressure difference between the two arms, a weak or absent pulse on one side, or a murmur heard over a vessel brings this diagnosis to mind. Vessel murmurs should be listened to in the neck, under the collarbone, and in the abdomen; these regions are where the most commonly affected vessels run close to the surface. BLOOD PRESSURE SHOULD BE MEASURED IN BOTH ARMS, PULSES SHOULD BE COMPARED, and MURMURS OVER VESSELS SHOULD BE LISTENED TO. CONCERNING FINDINGS: SIGNIFICANT BLOOD PRESSURE DIFFERENCE BETWEEN THE TWO ARMS, WEAK OR NON-EXISTENT PULSE, VASCULAR MURMUR (neck, below the collarbone, abdomen). This examination REQUIRES NO TESTS and SHOULD BE DONE in the presence of UNEXPLAINED SYSTEMIC COMPLAINTS in a YOUNG PATIENT The same examination should be performed in children and adolescents Examination At the first assessment
CRITICAL TRAP — incorrectly measured blood pressure The fact that blood pressure measured in a patient with narrowed arm arteries is lower than the actual value is a major cause of silent organ damage in this disease and, despite the mechanism being simple, it is often overlooked. Blood pressure is measured on the arm, and if the artery leading to that arm is narrowed, the pressure measured by the cuff does not reflect the true pressure leaving the heart; the pressure beyond the narrowing has dropped. In this case, even though the patient’s central blood pressure is high, the measurement comes out as normal or low. The result is twofold: the patient is not diagnosed with high blood pressure and treatment is not started; additionally, as the patient is wrongly assumed to be hypotensive, blood pressure-lowering treatments may be avoided. Meanwhile, the high pressure continues to affect the heart, kidneys, and brain. Therefore, measurement should be done on both arms and the highest value should be taken as reference. In a patient with narrowed arm arteries, the blood pressure measured is lower than the actual value; although the patient is HYPERTENSIVE, they are wrongly assumed to have NORMAL or LOW BLOOD PRESSURE and are NOT TREATED. THIS CONDITION SILENTLY PROGRESSES ORGAN DAMAGE. RULE: Both ARMS and, if necessary, LEGS should be measured, and the HIGHEST VALUE should be taken as the reference. Evaluation MUST BE CONFIRMED BY INSTITUTIONAL PROTOCOL THE SAME RULE APPLIES TO CHILDREN Examination With each measurement
Findings related to artery narrowing Recognizing the findings related to artery narrowing shows which artery region is affected and this information determines the follow-up plan. Narrowing of the arteries leading to the arms causes pain and quick fatigue when the arm is used; the patient may report that their arm feels heavy when combing hair or hanging something. Involvement of the arteries to the head and neck causes dizziness, fainting, and blurred vision. Narrowing of the renal artery manifests as unexplained high blood pressure in a young patient; this is an important finding that requires investigation for this diagnosis in young hypertension patients. Involvement of the intestinal arteries causes abdominal pain after eating, and the patient may lose weight due to fear of eating. Since these findings indicate that narrowing is developing, evaluation should not be delayed. PAIN AND FATIGUE IN THE ARM WHEN USED (arm claudication), DIZZINESS, FAINTING AND BLURRED VISION (head-neck arteries), UNEXPLAINED HIGH BLOOD PRESSURE IN A YOUNG PATIENT (renal artery narrowing), ABDOMINAL PAIN AFTER EATING (intestinal arteries), FATIGUE IN THE LEG. THESE FINDINGS INDICATE THAT NARROWING IS DEVELOPING AND EVALUATION SHOULD NOT BE DELAYED High blood pressure may be prominent in children — In the evaluation
THE MOST CHALLENGING PART — disease activity cannot be reliably measured The inability to reliably measure disease activity is the most challenging part of managing this disease and leads to both under- and overtreatment. In many inflammatory diseases, blood tests reasonably indicate how active the disease is; here this relationship is weak. Imaging in a patient whose markers have normalized and who has no complaints may show ongoing inflammation in the vessel wall and newly developing stenoses. The opposite can also occur: in a patient with high markers, the disease may actually be silent, and the elevation may be due to another cause. This uncertainty means that monitoring cannot be based on a single criterion; clinical complaints, physical examination findings, and imaging should be evaluated together. Therefore, physical examination holds high value in monitoring. DISEASE ACTIVITY CANNOT BE RELIABLY MEASURED: VASCULAR DAMAGE CAN PROGRESS EVEN WHEN INFLAMMATORY MARKERS ARE NORMAL. THEREFORE, MONITORING CANNOT BE BASED SOLELY ON MARKERS; CLINICAL FINDINGS, PHYSICAL EXAM (blood pressure and pulse), and IMAGING are evaluated together. The imaging method and intervals must be confirmed by the INSTITUTIONAL PROTOCOL In children, imaging modality is chosen considering radiation exposure — Regular
Principles of treatment and corticosteroid balance The long-term side effects of cortisone causing particularly severe outcomes in this patient group are due to the patients being young. This disease usually begins in women in their twenties and thirties; the treatment lasts for years. Long-term cortisone use reduces bone density in this age group, causes weight gain, changes skin appearance, and affects mood. Since these effects directly and visibly alter the life of a young patient, adherence to treatment is disrupted; patients want to reduce or stop the medication. Therefore, cortisone-reducing treatments should be considered early, and cortisone should be kept at the lowest effective dose. Bone protection should be planned at the beginning of treatment. These issues should be discussed openly with the patient, because if not mentioned, the patient may stop the medication on their own. THE FOUNDATION OF TREATMENT IS TO SUPPRESS INFLAMMATION; CORTICOSTEROIDS are effective but ALONE ARE NOT A LONG-TERM SOLUTION, and CORTICOSTEROID-SPARING THERAPY is usually added. SINCE PATIENTS ARE YOUNG, LONG-TERM CORTICOSTEROID use requires monitoring for GROWTH, BONE, WEIGHT, and PSYCHOLOGICAL EFFECTS (relevant protocols). Drug choices must be confirmed by the INSTITUTIONAL PROTOCOL and SPECIALIST OPINION The effect on growth in children should also be monitored. — The reason why long-term
Timing of intervention and surgical decision The timing of intervention and surgical decision directly determines the success of the procedure in this disease and this information should be shared with the team planning the vascular procedure. Opening a narrowed vessel or performing a bypass is technically feasible; however, results are poor if done while inflammation persists in the vessel wall. Inflamed tissue does not heal, the suture line causes problems, and the opened vessel re-narrows quickly. Therefore, the procedure should be planned after inflammation is suppressed whenever possible. This rule, combined with the inability to reliably measure disease activity, creates a difficult decision; therefore, the decision should not be made by a single physician but in consultation between rheumatology and vascular surgery. Emergency situations with organ threat are exceptions to this rule. INTERVENTION or SURGERY FOR STENOSIS carries a HIGH RISK of FAILURE and RE-NARROWING if PERFORMED WHILE THE DISEASE IS ACTIVE; therefore, it is planned AFTER INFLAMMATION IS SUPPRESSED whenever possible. Situations with EMERGENCY ORGAN THREAT are an exception. The decision is made with MULTIDISCIPLINARY evaluation and should be VERIFIED BY INSTITUTIONAL PROTOCOL. In children, growth is considered in planning — According to specialist decision
Pregnancy and long-term vascular risk Pre-planned pregnancy is crucial in this disease for both the mother and the baby because the patients are of childbearing age. During pregnancy, blood volume and cardiac workload increase; these changes can cause problems in a patient with narrowed vessels. Additionally, high blood pressure is already common in these patients, and the risk of preeclampsia increases during pregnancy; incorrect measurement of blood pressure in a patient with narrowed arm vessels is even more dangerous during pregnancy because the elevation may go unnoticed. Therefore, pregnancy should be planned while the disease is in a silent phase, the medications being used should be reviewed, and monitoring should be conducted jointly by rheumatology and perinatology. In the long term, cardiovascular risk is also increased, and modifiable risks should be managed. SINCE PATIENTS ARE OF REPRODUCTIVE AGE, PREGNANCY SHOULD BE PLANNED IN ADVANCE: it is planned while the disease is QUIET, MEDICATION SUITABILITY is reviewed, and the risks of BLOOD PRESSURE MANAGEMENT and PREGNANCY TOXEMIA are additionally addressed (according to relevant protocols). IN ADDITION, LONG-TERM CARDIOVASCULAR RISK IS INCREASED and MODIFIABLE RISKS should be managed. The topic should be appropriately addressed in adolescent patients. — The reason why long-term

Alternative

  • Giant cell arteritis occurs at an older age and the location of involvement is different (relevant protocol).
  • Narrowing due to arteriosclerosis occurs at an older age and along with risk factors.
  • Fibromuscular dysplasia causes renal artery narrowing in young women.
  • Vascular involvement in Behçet's disease can present with similar findings (relevant protocol).
  • ANCA-associated vasculitis affects small vessels and has a different course (relevant protocol).
  • IgG4-related disease may resemble involvement around the aorta (relevant protocol).
  • Infectious aortitis can be confused with fever and vascular involvement.
  • Aortic coarctation causes a blood pressure difference between the arms and legs in young patients.
  • Connective tissue diseases can involve the aorta.
  • Systemic lupus erythematosus causes systemic complaints in young women (relevant protocol).

Red flags

  • Considering SYSTEMIC COMPLAINTS IN THE FIRST STAGE as psychological or due to anemia → this interpretation is easily made because the patient APPEARS YOUNG AND OTHERWISE HEALTHY; at this stage, VASCULAR DAMAGE CAN STILL BE PREVENTED.
  • Measuring BLOOD PRESSURE FROM ONLY ONE ARM and NOT COMPARING PULSES → this examination REQUIRES NO TESTS and shows the MOST PROMINENT PHYSICAL SIGN OF THE DISEASE.
  • Not listening to VASCULAR MURMURS → the neck, subclavian, and abdomen are the places where the most commonly involved vessels pass close to the surface.
  • CRITICAL: Mistaking the low blood pressure measured in a patient with narrowed arm artery as REAL → the pressure measured by the cuff is the pressure beyond the NARROWING; the patient is considered to have NORMAL or LOW blood pressure despite being HYPERTENSIVE.
  • The TWO-WAY CONSEQUENCE of this trap: the patient is NOT DIAGNOSED WITH HIGH BLOOD PRESSURE and TREATMENT IS NOT STARTED; additionally, thinking the patient is HYPOTENSIVE, blood pressure-lowering treatments are AVOIDED — meanwhile, HIGH PRESSURE continues to affect the HEART, KIDNEYS, and BRAIN.
  • Failure to investigate unexplained high blood pressure in a YOUNG PATIENT → it may be due to RENAL ARTERY NARROWING.
  • Relying solely on INFLAMMATORY MARKERS for monitoring → VASCULAR DAMAGE can progress even when MARKERS are NORMAL; conversely, HIGH MARKERS may be due to ANOTHER CAUSE.
  • Considering a patient with MARKERS RETURNED TO NORMAL as recovered → imaging may show that INFLAMMATION IN THE VASCULAR WALL persists and NEW NARROWINGS have developed.
  • Underestimating the effects of LONG-TERM CORTISONE in this young patient group → effects on BONE DENSITY, WEIGHT, SKIN APPEARANCE, and MOOD disturb TREATMENT ADHERENCE, and the patient may STOP THE MEDICATION ON THEIR OWN.
  • Not planning BONE PROTECTION at the start of treatment (relevant protocol).
  • Performing VASCULAR ACCESS or SURGERY while the DISEASE IS ACTIVE → the INFLAMED TISSUE DOES NOT HEAL WELL, the SUTURE LINE CAUSES PROBLEMS, and the OPENED VESSEL NARROWS AGAIN IN A SHORT TIME.
  • Not planning PREGNANCY in advance → BLOOD VOLUME and HEART LOAD increase during pregnancy; additionally, the TRAP OF INCORRECT BLOOD PRESSURE MEASUREMENT is MORE DANGEROUS DURING PREGNANCY because HIGH PRESSURE MAY NOT BE DETECTED.
  • Not considering LONG-TERM CARDIOVASCULAR RISK → risk is INCREASED in these patients.

Disposition and follow-up

Green zone
Patient whose diagnosis is established, disease is under control, blood pressure is measured and managed correctly, and who is monitored with imaging: outpatient rheumatology follow-up.
Yellow zone
New diagnostic suspicion (young patient with systemic complaints with pulse or blood pressure difference), new narrowing finding, progression despite treatment, patient who cannot be weaned from cortisone, pregnancy planning: accelerated evaluation and joint assessment by rheumatology and vascular surgery.
Red zone
Sudden vision loss, signs of stroke, or changes in consciousness: emergency evaluation (relevant protocols). Sudden and severe chest or back pain: emergency evaluation for aortic dissection (relevant protocol). Severe abdominal pain after eating and general condition deterioration: emergency evaluation for intestinal vessel blockage. Sudden coldness, paleness, and loss of pulse in the arm or leg: emergency vascular assessment. Uncontrolled high blood pressure with signs of organ damage: emergency evaluation (relevant protocol).

Key clinical points

READ FIRST — CRITICAL TRAP: inaccurately measured blood pressure

THE MAIN CAUSE OF SILENT ORGAN DAMAGE IN THIS DISEASE; OFTEN OVERLOOKED DESPITE ITS SIMPLE MECHANISM | MECHANISM: blood pressure is measured on the ARM, and if the artery going to THAT ARM is narrowed, the pressure measured by the cuff DOES NOT REFLECT THE TRUE PRESSURE LEAVING THE HEART — BEYOND THE NARROWING, PRESSURE HAS DROPPED | RESULT: even though the patient's CENTRAL BLOOD PRESSURE IS HIGH, the measurement appears NORMAL or LOW | THE DAMAGE IS TWO-FOLD: (1) the patient is NOT DIAGNOSED WITH HIGH BLOOD PRESSURE and treatment is NOT STARTED | (2) the patient is MISTAKEN FOR HYPOTENSIVE and blood pressure-lowering treatments are AVOIDED | IN THE MEANTIME, HIGH PRESSURE CONTINUES TO AFFECT THE HEART, KIDNEYS, AND BRAIN | RULE: MEASURE FROM BOTH ARMS AND, IF NECESSARY, FROM THE LEG; THE HIGHEST VALUE IS TAKEN AS REFERENCE | THE SAME EXAM ALSO SUGGESTS THE DIAGNOSIS — THE CHEAPEST AND FASTEST STEP, REQUIRES NO TESTS AND TAKES ONLY A FEW MINUTES | HOWEVER, ROUTINE BLOOD PRESSURE IS USUALLY MEASURED FROM ONE ARM ONLY AND PULSES ARE NOT COMPARED → THE MOST PROMINENT PHYSICAL SIGN OF THE DISEASE IS OVERLOOKED | CONCERNING FINDINGS: A SIGNIFICANT DIFFERENCE BETWEEN BOTH ARMS | WEAK OR IMPALPABLE PULSE | VASCULAR MURMUR — LISTENED TO IN THE NECK, SUBCLAVIAN, AND ABDOMEN (places where commonly affected vessels pass close to the surface)

In a patient with a narrowed arm artery, the blood pressure measured is lower than the actual value and is the main cause of silent organ damage in this disease. The pressure measured by the cuff reflects the pressure beyond the narrowing, and although the patient's central blood pressure is high, the measurement appears normal. The damage is two-fold: the high blood pressure is not diagnosed and treatment is not started, and additionally, the patient is mistaken as hypotensive and blood pressure-lowering treatments are avoided; meanwhile, high pressure continues to affect the organs. Measurement should be done from both arms, and the highest value should be used as reference. The same examination also suggests the diagnosis; a difference between the arms, weak pulse, and vascular murmur suggest this diagnosis.

DELAY IN DIAGNOSIS — Two-stage course and young women bias

DELAY IN DIAGNOSIS IS ALMOST INEVITABLE IN THIS DISEASE AND THE COST IS PERMANENT VASCULAR DAMAGE | FIRST STAGE: inflammation has started in the vessel wall, but the VESSEL HAS NOT YET SIGNIFICANTLY NARROWED → the patient's complaints are ONLY GENERAL ILLNESS SYMPTOMS: FATIGUE | FEVER | WEIGHT LOSS | NIGHT SWEATS | MUSCLE and JOINT PAIN | THESE ARE SYMPTOMS THAT CAN BE SEEN IN ALMOST ANY DISEASE and are often ATTRIBUTED TO OTHER CAUSES in a young woman — considered PSYCHOLOGICAL or DUE TO ANEMIA | During this period, INFLAMMATORY MARKERS may be HIGH, but THIS IS ALSO NOT SPECIFIC | SECOND STAGE: when vessel narrowing progresses, SYMPTOMS APPEAR and DIAGNOSIS BECOMES RELATIVELY EASY — HOWEVER, AT THAT STAGE, STRUCTURAL DAMAGE TO THE VESSEL WALL DOES NOT REVOLVE | THEREFORE, IT IS IMPORTANT TO CATCH THE PATIENT IN THE FIRST STAGE | SIGNS OF NARROWING and THEIR LOCATION: Pain INCREASES WITH ARM USE and QUICK FATIGUE (vessels supplying the arms — the patient says her ARM BECOMES HEAVY when COMBING HER HAIR or HANGING SOMETHING) | DIZZINESS, FAINTING, BLURRED VISION (head and neck vessels) | UNEXPLAINED HIGH BLOOD PRESSURE IN A YOUNG PATIENT (renal artery narrowing — this DIAGNOSIS should be INVESTIGATED in young hypertension patients) | ABDOMINAL PAIN AFTER MEALS (intestinal vessels — the patient may LOSE WEIGHT by FEARING FOOD) | LEG FATIGUE

The two-stage course of the disease makes delay in diagnosis almost inevitable. In the first stage, inflammation has started in the vessel wall, but the vessel has not narrowed yet; the complaints are only general illness symptoms and in a young woman are often considered psychological or due to anemia. In the second stage, when narrowing progresses, diagnosis becomes easier but structural damage is irreversible, so it is important to catch the patient in the first stage. Signs of narrowing indicate which area is affected: pain increasing with arm use, dizziness and blurred vision, unexplained high blood pressure in a young patient, abdominal pain after meals.

THE MOST CHALLENGING PART — disease activity cannot be reliably measured

The most difficult aspect in managing this disease leads to both under- and overtreatment | In many inflammatory diseases, blood tests reasonably show how active the disease is; here this relationship is weak | Direction 1: Imaging performed in a patient whose markers have returned to normal and who has no complaints may show that inflammation in the vessel wall continues and new narrowings are developing | Direction 2: In a patient with elevated markers, the disease may actually be silent and the elevation may be due to another cause | Conclusion: Monitoring cannot rely on a single measure — clinical complaints, physical examination findings (blood pressure and pulse), and imaging are evaluated together | Therefore, the value of the examination in monitoring is high | Timing of intervention — when combined with this uncertainty, leads to a difficult decision: opening or bypassing a narrowed vessel is a technically feasible procedure, but when performed while inflammation in the vessel wall continues, the outcomes are poor — inflamed tissue does not heal, the suture line causes problems, and the opened vessel narrows again quickly | Rule: when the procedure is possible, it is planned AFTER inflammation is suppressed and the decision is made not by a single physician, but by a joint evaluation of Rheumatology and Vascular Surgery | Emergency situations with organ threat are exceptions to this rule

Unreliable measurement of disease activity is the most difficult aspect in managing this disease. Imaging in a patient whose markers have returned to normal may show persisting inflammation and new narrowing; conversely, high markers may be due to another cause. Monitoring cannot rely on a single criterion; clinical findings, examination, and imaging should be evaluated together, and therefore the value of examination in monitoring is high. When combined with this uncertainty, the timing of intervention creates a difficult decision: performing a procedure while inflammation in the vessel wall continues results in non-healing inflamed tissue, and the opened vessel quickly narrows again; therefore, the decision should be made jointly.

Corticosteroid load and pregnancy planning in a young patient

LONG-TERM SIDE EFFECTS OF CORTISONE HAVE PARTICULARLY SERIOUS CONSEQUENCES IN THIS GROUP because THE PATIENTS ARE YOUNG | The disease usually starts in WOMEN IN THEIR TWENTIES AND THIRTIES; TREATMENT LASTS FOR YEARS | LONG-TERM CORTISONE in this age group: REDUCES BONE DENSITY | CAUSES WEIGHT GAIN | CHANGES SKIN APPEARANCE | AFFECTS MOOD | THESE EFFECTS DIRECTLY AND VISIBLY CHANGE THE LIFE OF A YOUNG PATIENT AND DISRUPT TREATMENT ADHERENCE — patients WANT TO REDUCE OR STOP THE MEDICATION | RULE: CORTISONE-REDUCING TREATMENTS ARE CONSIDERED EARLY, cortisone is KEPT AT THE LOWEST EFFECTIVE DOSE, and BONE PROTECTION is planned AT THE START OF TREATMENT | THESE ISSUES ARE EXPLICITLY DISCUSSED WITH THE PATIENT because IF NOT MENTIONED, THE PATIENT MAY STOP THE MEDICATION ON THEIR OWN | PREGNANCY — PATIENTS ARE OF CHILD-BEARING AGE, SO IT IS PLANNED IN ADVANCE: blood volume and cardiac workload increase during pregnancy, and these changes CAN CAUSE PROBLEMS in patients with NARROWED VESSELS | HIGH BLOOD PRESSURE is ALREADY COMMON in these patients, and the RISK OF PREECLAMPSIA increases during pregnancy | THE TRAP OF INCORRECT BLOOD PRESSURE MEASUREMENT IS MORE DANGEROUS DURING PREGNANCY because HIGH BLOOD PRESSURE MAY NOT BE NOTICED | Pregnancy is planned WHILE THE DISEASE IS IN THE QUIESCENT PHASE, MEDICATIONS are reviewed, and follow-up is jointly conducted by RHEUMATOLOGY and PERINATOLOGY | IN THE LONG TERM, CARDIOVASCULAR RISK ALSO INCREASES and MANAGEABLE RISKS are controlled

Long-term side effects of cortisone have particularly serious consequences in this group because the patients are young women and the treatment lasts for years. Decreased bone density, weight gain, changes in skin appearance, and mood effects visibly alter the life of a young patient and disrupt adherence; therefore, cortisone-reducing treatments should be considered early, and bone protection should be planned from the beginning. Pregnancy should be planned in advance because blood volume and cardiac load increase; moreover, the trap of incorrect blood pressure measurement is more dangerous during pregnancy because high blood pressure may go unnoticed.

Detailed assessment

Diagnostic and decision reasoning

Clinical framework

Overview

Takayasu arteritis is a vascular inflammation that affects large arteries and is usually seen in women under forty years old. Delayed diagnosis is a hallmark of this disease, and its reason is the two-phase course of the disease.

In the first phase, symptoms are not specific to any organ and are often attributed to psychological causes or anemia in a young woman. In the second phase, the arteries are narrowed and findings emerge, but by this stage, vascular damage has already occurred.

The most cost-effective step to suggest the diagnosis is physical examination: measuring blood pressure from both arms and comparing pulses. A critical pitfall is that the blood pressure measured in a patient with narrowed arm arteries will appear lower than the actual value.

The most challenging aspect is that the disease activity cannot be reliably measured.

Differential diagnosis and assessment

Key considerations

  • Giant cell arteritis occurs at an older age and the location of involvement is different (relevant protocol).
  • Narrowing due to arterial stiffness is seen in older age and with risk factors.
  • Fibromuscular dysplasia causes renal artery narrowing in young women.
  • Vascular involvement in Behçet’s disease can give similar findings (related protocol).
  • ANCA-associated vasculitis affects small vessels (related protocol).
  • IgG4-related disease may resemble involvement around the aorta (relevant protocol).
  • Infectious aortitis can be confused with fever and vascular involvement.
  • Coarctation of the aorta causes a difference in arm and leg pressures.
  • Connective tissue diseases can involve the aorta.
  • Systemic lupus erythematosus causes systemic complaints in young women (relevant protocol).

Clinical decision reasoning

Why it matters

In this disease, the points that determine the clinical outcome are whether an examination was performed and whether the measurements were interpreted correctly. The first point is the two-phase course; in the first phase, symptoms are non-specific and attributed to other causes in a young woman.

The second and most practical point is measuring blood pressure from both arms; it requires no tests but is not done routinely. The third and critical point is wrongly measured blood pressure; although the patient is hypertensive, they are thought to be normal, and organ damage silently progresses.

The fourth point is that activity cannot be reliably measured; follow-up cannot be based on a single criterion. The fifth point is the timing of intervention; procedures done while inflammation persists will fail.

The last point is corticosteroid load and pregnancy planning in the young patient group.

Safety and monitoring

Complications and safety

Critical complications

  • Permanent narrowing and occlusion develop in the arteries.
  • Uncontrolled hypertension due to wrongly measured blood pressure causes organ damage.
  • Stroke, vision loss, and loss of consciousness may occur.
  • Aortic dilation and rupture may develop.
  • Kidney function impairment occurs due to renal artery stenosis.
  • Intestinal vessel occlusion and nutritional disorders are seen.
  • Long-term corticosteroid use causes bone loss and metabolic effects.
  • Vascular interventions performed while the disease is active fail and restenosis is observed.

Special patient populations

Special considerations

  • The disease is most common in young women, and pregnancy planning should be addressed in advance.
  • This diagnosis should be investigated in young patients with hypertension.
  • In patients with narrowed arm arteries, blood pressure should be managed based on the highest measurement.
  • Pregnancy follow-up should be conducted jointly by rheumatology and perinatology.
  • In patients using long-term corticosteroids, bone protection should be planned initially.
  • In patients scheduled for vascular intervention, disease activity should be evaluated beforehand.
  • It also occurs in children and adolescents, and growth should be monitored.
  • Since cardiovascular risk is increased, modifiable risk factors should be managed.

Follow-up and reassessment

Follow-up plan

Takayasu arteritis follow-up cannot be based on a single criterion and should include clinical evaluation, physical examination, and imaging together. At each visit, blood pressure should be measured from both arms, pulses compared, and vascular bruits auscultated; this examination is the most valuable and cheapest part of monitoring.

Blood pressure management should be based on the highest measured value. Signs of new stenosis should be directly questioned; patients should be asked about pain with arm use, dizziness, blurred vision, and postprandial abdominal pain.

Inflammatory markers should be monitored but should not be used alone as a decision tool. Imaging follow-up should be planned, and intervals should be determined according to the course of the disease.

Corticosteroid doses should be reviewed at each check-up, and bone health and metabolic side effects should be monitored. Pregnancy planning should be asked about and addressed in advance.

Cardiovascular risk factors should be managed regularly.

Structured references

  1. Maz M ve ark. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Care Res / Arthritis Rheumatol, 2021,Mehrdad Maz, Sharon A. Chung, Andy Abril, Carol A. Langford, Mark Gorelik, Gordon Guyatt, et al.Arthritis Care & Research · 2021 DOI: 10.1002/acr.24632
  2. Hellmich B, Agueda A, Monti S, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2020;79(1):19-30. — büyük damar vaskülitlerinde izlem ilkeleri ve etkinlik değerlendirmesinin sınırları. DOĞRULANMALI2020
  3. Kim ESH, Beckman J. Takayasu arteritis: challenges in diagnosis and management. Heart 2018;104(7):558-565. — kan basıncı ölçümü tuzağı, damar girişimi kararı ve uzun dönem izlem. DOĞRULANMALI2018
  4. Kaynak bölüm: Kelley & Firestein's Textbook of Rheumatology 10e — Bölüm 88 (Dev hücreli arterit, polimiyalji romatika ve Takayasu arteriti), Türkçe çeviri (kullanıcı arşivi). Genel çerçeve ve kapsam referansı. DOĞRULANMALI

Last reviewed: 2026-08-06 · Review due: 2027-08-06

This protocol is intended solely for physician bedside DECISION SUPPORT and does not replace independent clinical judgment. DIAGNOSTIC and CLASSIFICATION CRITERIA, THRESHOLD VALUES FOR BLOOD PRESSURE DIFFERENCES, SELECTION OF IMAGING METHOD and MONITORING INTERVALS, INITIAL CORTISONE DOSE and TAPERING SCHEME, CORTISONE-SPARING DRUG SELECTIONS and DOSES, VASCULAR ACCESS CRITERIA and BLOOD PRESSURE TARGETS are deliberately not provided; they must be verified with INSTITUTIONAL PROTOCOLS and EXPERT OPINION because they vary according to the patient, the accessed vascular region, and the center's practice. Giant cell arteritis is addressed in a SEPARATE PROTOCOL. CRITICAL SAFETY: (1) IN PATIENTS WITH NARROWED ARM ARTERIES, THE MEASURED BLOOD PRESSURE APPEARS LOWER THAN THE TRUE VALUE — the patient may be HYPERTENSIVE yet considered NORMAL or UNDERPRESSURE, remain UNTREATED, and ORGAN DAMAGE PROGRESSES SILENTLY; measurements should be made on BOTH ARMS, and the HIGHEST VALUE should be taken as the reference; (2) MEASUREMENT FROM BOTH ARMS and PULSE COMPARISON REQUIRES NO TESTS and shows the MOST DISTINCT PHYSICAL FINDING of the disease; (3) SYSTEMIC SYMPTOMS IN THE EARLY STAGE SHOULD NOT BE ATTRIBUTED TO PSYCHOLOGICAL FACTORS or ANEMIA IN YOUNG WOMEN — VASCULAR DAMAGE AT THIS STAGE IS STILL PREVENTABLE; (4) DISEASE ACTIVITY CANNOT BE RELIABLY MEASURED — VASCULAR DAMAGE MAY PROGRESS EVEN WHEN INFLAMMATORY MARKERS ARE NORMAL; monitoring cannot rely solely on markers; (5) UNEXPLAINED HYPERTENSION IN YOUNG PATIENTS SHOULD BE INVESTIGATED FOR RENAL ARTERY STENOSIS; (6) VASCULAR ACCESS CARRIES HIGH RISK OF FAILURE AND RECURRENT NARROWING WHEN PERFORMED WHILE THE DISEASE IS ACTIVE; decisions should be made MULTIDISCIPLINARILY; (7) SINCE PATIENTS ARE YOUNG, LONG-TERM CORTISONE IMPACTS BONE, WEIGHT, SKIN, AND PSYCHOLOGICAL HEALTH, AFFECTING TREATMENT ADHERENCE; BONE PROTECTION SHOULD BE PLANNED FROM THE START; (8) PREGNANCY SHOULD BE PLANNED IN ADVANCE, AND THE PITFALL OF INCORRECT BLOOD PRESSURE MEASUREMENT IS MORE DANGEROUS DURING PREGNANCY. Giant cell arteritis, organ involvement in Behçet's disease, ANCA-associated vasculitis, and rheumatic diseases in pregnancy are addressed in separate protocols. Content requires expert manual verification.